Advanced Life Support: Respiratory Emergencies; Enduring Web Course
Original Release Date: 12/12/2022
Last Review Date: November 2022
Termination Date: 12/11/2025
This module will cover several of the most common respiratory emergencies, including severe asthma, cardiogenic pulmonary edema, anaphylaxis, peri-intubation arrest, pulmonary embolism, and noncardiogenic pulmonary edema. Identification of signs and symptoms, descriptions of treatments, potential complications, and considerations will be presented. The goal of this module is to treat these respiratory emergencies before they lead to cardiac arrest.
At the conclusion, participants should be able to:
Recognize and explain treatment for severe asthma
Recognize and explain treatment for cardiogenic pulmonary edema
Recognize and explain treatment for anaphylaxis
Recognize and explain treatment for peri-intubation arrest
Recognize and explain treatment for pulmonary hypertension due to pulmonary embolism
Recognize and explain treatment for noncardiogenic pulmonary edema due to narcotics overdose
Joint Accreditation: 12/12/2022 - 12/11/2025
CAPCE: 12/12/2022 - 12/11/2025
In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Heart Association designates this activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation and Successful Completion
Successful completion of this CE activity includes the following:
Complete all portions of the online course
Complete the course evaluation
Print the Certificate/Statement of Credit
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.
The following authors/faculty have declared NO financial interest(s) and/or affiliations (check for not conflicts):
Gustavo E. Flores, MD, NRP, FP-C
Sallie Johnson, PharmD, BCPS
Kenneth Navarro, MEd, LP
Elizabeth H. Sinz, MD, MEd
Comilla Sasson, MD, PhD
The list represents the relationships that may be perceived as actual or reasonable conflicts of interest as reported on the Disclosure Questionnaire, which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 24-month period preceding the time that the individual is being asked to assume a role controlling content:
Brian K. Walsh, PhD, RRT: Vapotherm - Researcher, Elsevier - Book Royalties, VERO Biotech - Advisor, FluidIQ - Employee and ownership interest
The American Heart Association and American Stroke Association strive to make our websites accessible. The American Heart Association and American Stroke Association are committed to diversity, inclusion, and meeting the needs of all our constituents, including those with disabilities. We are continually improving our digital assets to comply with the accessibility guidelines for levels A and AA in accordance with WCAG 2.1.
If the format of any material on our web pages interferes with your ability to access the information, please contact us to request assistance or if you have questions or comments about our web sites’ accessibility.